We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
-19.16%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$209M
AUM Growth
-$61.5M
Cap. Flow
-$6.19M
Cap. Flow %
-2.97%
Top 10 Hldgs %
33.03%
Holding
137
New
8
Increased
35
Reduced
61
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 20.69%
2 Consumer Staples 13.41%
3 Technology 11.29%
4 Financials 11%
5 Communication Services 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHE icon
26
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
$2.66M 1.28%
128,753
-7,997
-6% -$200K
SCHM icon
27
Schwab US Mid-Cap ETF
SCHM
$14.9B
$2.41M 1.16%
171,765
-11,067
-6% -$203K
NVDA icon
28
NVIDIA
NVDA
$5.3T
$2.35M 1.12%
355,840
-219,800
-38% -$1.39M
CERN
29
DELISTED
Cerner Corp
CERN
$2.29M 1.1%
36,359
-6,391
-15% -$455K
EEFT icon
30
Euronet Worldwide
EEFT
$2.73B
$2.22M 1.06%
25,905
+18,320
+242% +$2.43M
SCHA icon
31
Schwab U.S Small- Cap ETF
SCHA
$22.8B
$2.16M 1.04%
167,644
-43,124
-20% -$733K
STZ icon
32
Constellation Brands
STZ
$22.6B
$1.99M 0.96%
13,902
-75
-0.5% -$13.2K
MCD icon
33
McDonald's
MCD
$196B
$1.99M 0.95%
12,033
-1,440
-11% -$284K
TFC icon
34
Truist Financial
TFC
$64.2B
$1.96M 0.94%
63,485
+4,744
+8% +$224K
NVO
35
Novo Nordisk
NVO
$203B
$1.95M 0.94%
64,928
-1,750
-3% -$52.1K
GILD icon
36
Gilead Sciences
GILD
$162B
$1.91M 0.92%
25,550
-10,270
-29% -$710K
GSK icon
37
GSK
GSK
$104B
$1.9M 0.91%
40,052
+388
+1% +$20.7K
CFFN icon
38
Capitol Federal Financial
CFFN
$1.11B
$1.89M 0.91%
163,086
-17,845
-10% -$229K
SCHW
39
Charles Schwab
SCHW
$187B
$1.88M 0.9%
55,777
-1,125
-2% -$47.2K
MMM icon
40
3M
MMM
$93.2B
$1.86M 0.89%
16,335
+3,594
+28% +$473K
CTSH icon
41
Cognizant
CTSH
$25.6B
$1.79M 0.86%
+38,564
New +$2.3M
MO icon
42
Altria Group
MO
$113B
$1.78M 0.86%
46,140
-9,027
-16% -$401K
PM icon
43
Philip Morris
PM
$293B
$1.76M 0.84%
24,081
-3,725
-13% -$307K
JPM icon
44
JPMorgan Chase
JPM
$947B
$1.73M 0.83%
19,262
+2,476
+15% +$301K
KO icon
45
Coca-Cola
KO
$374B
$1.71M 0.82%
38,659
-2,058
-5% -$111K
DGX icon
46
Quest Diagnostics
DGX
$26.3B
$1.7M 0.82%
21,225
-1,575
-7% -$163K
ADP icon
47
Automatic Data Processing
ADP
$109B
$1.7M 0.82%
12,442
-1,485
-11% -$239K
SYY icon
48
Sysco
SYY
$40.4B
$1.65M 0.79%
36,180
-1,650
-4% -$114K
SO icon
49
Southern Company
SO
$107B
$1.65M 0.79%
30,401
-6,325
-17% -$401K
V icon
50
Visa
V
$692B
$1.59M 0.76%
9,883
+405
+4% +$76.3K

Similar funds

Kavar Capital Partners Group's Q1 2020 Portfolio in Review

As of Q1 2020, Kavar Capital Partners Group held 137 positions worth $209M, down 23% from $270M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Kavar Capital Partners Group's Q1 2020 filing shows 8 new, 35 increased, 61 reduced and 20 closed positions. Its largest new stake was Cognizant: 38,564 shares worth $1.79M. The largest sale was NVIDIA, an estimated $1.39M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Technology.

  • Kavar Capital Partners Group's largest Q1 2020 buy was Cognizant: 38,564 shares worth $1.79M.
  • Kavar Capital Partners Group added most to Euronet Worldwide in Q1 2020, an estimated $2.43M increase.
  • Kavar Capital Partners Group's biggest Q1 2020 reduction was NVIDIA, cutting an estimated $1.39M.
  • Kavar Capital Partners Group fully exited Molson Coors Class B in Q1 2020, selling an estimated $829K.
  • Kavar Capital Partners Group's ten largest holdings make up 33% of its $209M portfolio in Q1 2020.
  • Kavar Capital Partners Group opened 8 new positions and closed 20 in Q1 2020.
  • Kavar Capital Partners Group's portfolio value fell 23% quarter-over-quarter to $209M.

Based on Kavar Capital Partners Group's 13F filing for Q1 2020, filed 20 Apr 2020.